Published in Clin J Am Soc Nephrol on March 18, 2016
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol (1995) 5.51
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol (2014) 4.37
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol (2012) 3.35
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem (2005) 2.64
Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol (2001) 2.54
Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol (2009) 2.45
Nephrotoxic potential of Bence Jones proteins. N Engl J Med (1991) 2.24
Update on therapy of chronic lymphocytic leukemia. J Clin Oncol (2011) 2.19
Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol (2011) 2.14
Screening panels for detection of monoclonal gammopathies. Clin Chem (2009) 2.05
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int (2013) 1.79
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia (2010) 1.76
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood (2012) 1.75
Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol (2006) 1.75
Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis (2003) 1.73
Dangerous small B-cell clones. Blood (2006) 1.70
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol (2012) 1.69
Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) (2000) 1.61
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol (2015) 1.61
Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol (2011) 1.58
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol (2011) 1.57
Diagnosis of monoclonal gammopathy of renal significance. Kidney Int (2015) 1.53
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant (2011) 1.51
Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clin Chem (2002) 1.49
Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis (2004) 1.46
Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol (2010) 1.45
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol (2008) 1.39
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol (2011) 1.38
How I treat monoclonal gammopathy of renal significance (MGRS). Blood (2013) 1.33
Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations. Haematologica (2010) 1.32
Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol (2011) 1.31
Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int (2010) 1.24
C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis (2013) 1.24
Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am J Kidney Dis (2012) 1.19
Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol (2013) 1.19
Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int (2002) 1.18
High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int (2004) 1.15
Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis (2003) 1.11
Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis (2005) 1.09
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL). Cancer (2013) 1.07
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood (2004) 1.05
Nephrogenic diabetes insipidus caused by amyloid disease. Evidence in man of the role of the collecting ducts in concentrating urine. Am J Med (1960) 1.04
Mechanisms of light chain injury along the tubular nephron. J Am Soc Nephrol (2012) 0.97
A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrol Dial Transplant (1999) 0.97
Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med (1990) 0.96
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidney. Nephrol Dial Transplant (2011) 0.94
Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant (2010) 0.94
Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int (2008) 0.94
Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN). Clin Exp Immunol (1994) 0.94
Goodpasture syndrome: molecular and clinical advances. Medicine (Baltimore) (1994) 0.90
Are you sure this is Waldenstrom macroglobulinemia? Hematology Am Soc Hematol Educ Program (2012) 0.88
Renal disease in POEMS syndrome: report on a case and review of the literature. Nephrol Dial Transplant (1994) 0.87
Immunotactoid glomerulopathy: clinicopathologic and proteomic study. Nephrol Dial Transplant (2012) 0.86
Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc (2015) 0.86
Cryocrystalglobulinemia as a cause of systemic vasculopathy and widespread erosive arthropathy. Arthritis Rheum (1996) 0.86
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol (2012) 0.85
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? Haematologica (2013) 0.85
Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int (2015) 0.84
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease. Kidney Int (2015) 0.84
A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia. NDT Plus (2009) 0.84
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol (2013) 0.83
Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma. Am J Kidney Dis (2010) 0.81
Renal involvement in POEMS syndrome. Clin Nephrol (1995) 0.80
Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma. Clin Biochem (2002) 0.78
Ibrutinib: a paradigm shift in management of CLL. Expert Rev Hematol (2014) 0.77
Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma. Clin Nephrol (2015) 0.76
Automated multicapillary electrophoresis for analysis of human serum proteins. Clin Chem (2003) 0.76
Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both. Leuk Lymphoma (2015) 0.76
Proteasome inhibitor associated thrombotic microangiopathy. Am J Hematol (2016) 0.75
Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol (2016) 0.75
Dysproteinemias and Glomerular Disease. Clin J Am Soc Nephrol (2017) 0.75